INSUBCONTINENT EXCLUSIVE:
He envisions EMS generating $2 billion in international sales within eight years, matching its domestic revenue.The NC Group, which includes
EMS, reported impressive financial results last year
It boasted a total revenue of R$10.6 billion ($1.9 billion), with EMS accounting for 90% of that sum.The pharmaceutical arm has grown
consistently, averaging a 17% annual increase in net revenue over the past five years
It now plans to enter the US market with FDA approval, potentially becoming a major competitor in the diabetes and obesity medication
This facility specializes in producing synthetic molecules for diabetes and obesity treatments.Brazilian Pharmaceutical Giant EMS Sets
Sights on Global Expansion
(Photo Internet reproduction)It cost R$17 million ($3 million) to build and requires R$50 million ($9 million) annually to operate
Sanchez is planning his succession, intending to step down as president soon
The NC Group owns 28 companies across various sectors.However, Sanchez believes the pharmaceutical industry offers the best opportunity for
million worth of medical products while importing $7.2 billion
ability to innovate, navigate regulatory hurdles, and compete with established international players.
